The 2025 Annual Report reflects the continued commitment of Rosenau Family Research Foundation (RFRF) to improving the lives of individuals and families impacted by Krabbe disease and Cystic Fibrosis through research funding and advocacy.
Driven by research, advocacy, and collaboration, the Foundation remains committed to creating meaningful progress in the rare disease space. Throughout 2025, the organization focused on advancing foundational discovery, supporting translation to human application, accelerating new therapeutic strategies, and strengthening clinical knowledge and practice.
Explore the research, progress, and partnerships that defined 2025 for RFRF and our community: